Cognivia expands its portfolio of predictive solutions by introducing Compl-AI©™
Thursday, May 25, 2023
Cognivia , a clinical trial technology company that combines machine learning with sophisticated assessment of patient characteristics and traits, is proud to announce the launch of its latest innovation: Compl-AI ©™ .
Compl-AI is a predictive tool that helps clinical trial sponsors optimize patient recruitment and engagement strategies. Lack of adherence in clinical trials and high dropout rates make efficacy and safety more difficult to determine. Compl-AI addresses this common challenge by qualifying patient behavior on screening using machine learning. The Compl-AI Patient Behavior Score allows for individualized patient engagement strategies. Beyond clinical research, Compl-AI offers healthcare providers a unique approach to optimally personalize and tailor their patient support for better treatment adherence.
"Cognivia is dedicated to cracking the code of the complex relationship between patient traits and behavior," said CEO Dominique Demolle , PhD. "Individual patient characteristics and experiences have a significant impact on clinical trial data. With Compl-AI, we are excited about the potential to personalize patient engagement strategies and continue to drive drug development into a new frontier." ".